Prime Minister Joseph Muscat recently officially inaugurated the offices of Jesmond Mizzi Financial Advisors in Ħamrun.
Atlas Investment Services was set up in 1996 while Jesmond Mizzi Financial Services was launched in 2002. Managing director Jesmond Mizzi explained that five years ago the two agreed to merge.
In 2012, the company rebranded as Jesmond Mizzi Financial Advisors. Today it employs 21 people and operates from five locations around Malta.
This year the company intends to launch investment products which will be managed internally, and it is also aiming to provide new investment services for investors seeking discretionary services from investment advisors.
MFCC and Rocs reach agreement for trade fair
MFCC and Rocs have reached a long-term agreement, initially for three years, covering three major annual fairs including the national Malta Trade Fair, MFCC Amitex Holiday show and The MFCC Warehouse Sales.
Through the agreement, MFCC and Rocs will use their expertise, brand exposure, marketing clout and brand representation to boost attendance at each of the fairs.
Malta Fairs and Conventions Centre Limited (MFCC) is a wholly owned subsidiary of Catermax, which in turn is a 50/50 joint venture between the Corinthia and Vassallo groups of companies. The Rocs Group was set up in the early 70s by founder and chairman Charles Vella and is now established as a market leader in the travel, insurance, investments, media and retail sectors.
“MFCC recognises the strengths of the Rocs Group as a crowd puller,” MFCC managing director Gerald Borg said.
“We believe both parties can work together to deliver an enhanced and valuable event experience. This will, of course, also be beneficial to all other exhibitors taking part in both the MFCC Amitex Holiday Show and the MFCC Malta Trade Fair.”
Medichem Malta plant passes US FDA inspection
Medichem’s Maltese plant has passed, for the second consecutive time, a US Food and Drug Administration (FDA) inspection without receiving a single observation.
Medichem is a leading manufacturer of active ingredients for the pharmaceutical industry.
The inspection of Medichem’s plant in Ħal Far covered good manufacturing practice (GMP) systems, as well as several active pharmaceutical ingredients (APIs) exported to the US.
Medichem has been selling its products in the US market since the 1980s. Since then, the company’s premises in Malta and Spain have been regularly audited by the FDA. Its Spanish plant was given the thumbs up in its last five inspections.
Medichem has more than 250 people working at various locations and delivers products to more than 70 countries.
Medserv awarded €4m contract
Medserv has won a €4 million maintenance contract on a platform situated offshore in North Africa. The contract will commence in the second quarter of 2015 and is expected to be completed in 10 months.